A Message from the President

Video Message From the President


Hiroshi Nomura
Representative Director,
President and CEO

My name is Hiroshi Nomura, and I have the honor of serving as Representative Director, President and CEO of Sumitomo Dainippon Pharma Co., Ltd.

The single most important responsibility that I have been given is to ensure the sustainable growth of our company into the future. As such, I will make the most efficient use of all resources available to us, unite our individual strengths, and leverage our wealth of experience so that we can successfully take on this challenge. At the same time, I hope to meet the expectations of all stakeholders in our endeavors to attain this overriding goal.

Sumitomo Dainippon Pharma Co., Ltd., operates every day to achieve its corporate mission "to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide." By pouring all our efforts into the research and development of new drugs, we aim to provide innovative and valuable pharmaceutical solutions to people not only in Japan but also around the world in order to realize our corporate mission.

We will remain committed to research and development by taking every available opportunity to assimilate cutting-edge technologies through combinations of a wide variety of avenues, including in-house research, technology in-licensing, and joint research with academia and biotech companies, with the aim of continually discovering excellent pharmaceutical products in our focus research areas of Psychiatry & Neurology, Oncology, and Regenerative Medicine & Cell Therapy. Furthermore, we will explore new businesses in the healthcare sector and offer solutions other than treatment by pharmaceutical products in order to gain opportunities to contribute to the well-being of people through the use of digital technologies and other methods.

Through these undertakings, we will aim to become a "global specialized player" whose presence is felt throughout the world in specific therapeutic areas.

To fulfill our social responsibilities as a corporation, we not only strengthen our corporate governance system and thoroughly ensure compliance but also take wide-ranging initiatives that include social contribution activities in and outside Japan, promotion of diversity and inclusion, and active communication with diverse stakeholders.

Always aware of our responsibility to all of our stakeholders, including patients, their families, medical caregivers, our shareholders, employees, and the communities in which we work, we promise to give our most dedicated efforts to earn and maintain your trust in us.

On behalf of all of us at Sumitomo Dainippon Pharma, I would like to sincerely thank you for your continued support and encouragement.